Medicamen Biotech Share Price

ABOUT Medicamen Biotech

• Industry Biotechnology & Drugs
• ISIN INE646B01010
• BSE Code 531146
• NSE Code MEDICAMEQ

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.

MANAGEMENT

• Rajesh Madan Chief Executive Officer
• Chandan Kumar Chief Financial Officer
• Parul Choudhary Compliance Officer, Company Secretary